Overview

Terbutaline Concentrations in Blood and Urine

Status:
Unknown status
Trial end date:
2010-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the blood and urine concentrations of terbutaline and to evaluate the difference between inhaled and oral terbutaline in order to distinguish treatment with terbutaline from doping with terbutaline in a doping control.
Phase:
Phase 4
Details
Lead Sponsor:
Bispebjerg Hospital
Collaborator:
Hormone Laboratory, Aker University Hospital, Oslo, Norway
Treatments:
Terbutaline